| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5503447 | Maturitas | 2017 | 24 Pages |
Abstract
A high proportion of falls in older adults are related to the use of BZDs. They should be prescribed to older patients in accordance with current clinical guidelines and reviewed over time. BZDs should be prescribed as a short-term therapy and progressively withdrawn. Short-acting BZDs should be the treatment of choice.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Mª José DÃaz-Gutiérrez, Mónica MartÃnez-Cengotitabengoa, EstÃbaliz Sáez de Adana, Ana Isabel Cano, Maria Teresa MartÃnez-Cengotitabengoa, Ariadna Besga, Rafael Segarra, Ana González-Pinto,